Jing Xiao

机构：Binzhou Medical University, Shandong University of Aeronautics, Yantaishan Hospital · ORCID：0000-0003-2965-6882

发表论文 7 篇 · 总被引 32 次 · h-index 3

代表论文

• LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway (2024 · Journal of Experimental & Clinical Cancer Research · 被引 19)
• Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment (2023 · Blood Advances · 被引 5)
• Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study (2022 · Journal of Healthcare Engineering · 被引 4)
• Chronic Subdural Hematoma Caused by Acute Myeloblastic Leukemia: A Case Report (2022 · Frontiers in Neurology · 被引 3)
• Caffeic acid tablets plus high-dose dexamethasone versus placebo plus high-dose dexamethasone in patients with newly diagnosed immune thrombocytopenia: A multicenter, double-blind, randomized, controlled, phase 2 trial (2025 · Chinese Medical Journal · 被引 1)
• Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study (2025 · Blood)